PROLIFERATIVE VITREORETINOPATHY

Clinical trials for PROLIFERATIVE VITREORETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new PROLIFERATIVE VITREORETINOPATHY trials appear

Sign up with your email to follow new studies for PROLIFERATIVE VITREORETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Completed 1

New eye drop aims to stop Vision-Threatening scarring after eye surgery

Disease control Recruiting now

This study is testing if a daily eye drop called netarsudil can prevent a serious complication called proliferative vitreoretinopathy (PVR), which is scarring that can cause the retina to detach again after surgery. Researchers will give the drops to 48 patients before and after …

Matched conditions: PROLIFERATIVE VITREORETINOPATHY

Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

PROLIFERATIVE VITREORETINOPATHY

Get alerted when new PROLIFERATIVE VITREORETINOPATHY trials appear

New eye drop aims to stop Vision-Threatening scarring after eye surgery